Abstract:Outer hair cell electromotility is a rapid, force generating, length change in response to electrical stimulation. DC electrical pulses either elongate or shorten the cell and sinusoidal electrical stimulation results in mechanical oscillations at acoustic frequencies. The mechanism underlying outer hair cell electromotility is thought to be the origin of spontaneous otoacoustic emissions. The ability of the cell to change its length requires that it be mechanically flexible. At the same time the structural in… Show more
“…Salicylates are well known to interfere with outer hair cell electromotility [31] and would be expected, therefore, to alter both DPOAEs and CAPs (with CAP alteration secondary to an effect on the hair cell). Consistent with this expectation, salicylate altered both CAP thresholds and low-level iso-DPOAEs, as displayed in Fig.…”
Section: Salicylate Perfusion Reversibly Affected Both Cap and Dpoaesmentioning
Rapid progress in understanding the molecular mechanisms associated with cochlear and auditory nerve degenerative processes offers hope for the development of gene-transfer and molecular approaches to treat these diseases in patients. For therapies based on these discoveries to become clinically useful, it will be necessary to develop safe and reliable mechanisms for the delivery of drugs into the inner ear, bypassing the blood-labyrinthine barrier. Toward the goal of developing an inner ear perfusion device for human use, a reciprocating microfluidic system that allows perfusion of drugs into the cochlear perilymph through a single inlet hole in scala tympani of the basal turn was developed. The performance of a prototype, extracorporeal reciprocating perfusion system in guinea pigs is described. Analysis of the cochlear distribution of compounds after perfusion took advantage of the place-dependent generation of responses to tones along the length of the cochlea. Perfusion with a control artificial perilymph solution had no effect. Two drugs with wellcharacterized effects on cochlear physiology, salicylate (5 mM) and DNQX (6,7-Dinitroquinoxaline-2,3-dione; 100 and 300 μM), reversibly altered responses. The magnitude of drug effect decreased with distance from the perfusion pipette for up to 10 mm, and increased with dose and length of application.
“…Salicylates are well known to interfere with outer hair cell electromotility [31] and would be expected, therefore, to alter both DPOAEs and CAPs (with CAP alteration secondary to an effect on the hair cell). Consistent with this expectation, salicylate altered both CAP thresholds and low-level iso-DPOAEs, as displayed in Fig.…”
Section: Salicylate Perfusion Reversibly Affected Both Cap and Dpoaesmentioning
Rapid progress in understanding the molecular mechanisms associated with cochlear and auditory nerve degenerative processes offers hope for the development of gene-transfer and molecular approaches to treat these diseases in patients. For therapies based on these discoveries to become clinically useful, it will be necessary to develop safe and reliable mechanisms for the delivery of drugs into the inner ear, bypassing the blood-labyrinthine barrier. Toward the goal of developing an inner ear perfusion device for human use, a reciprocating microfluidic system that allows perfusion of drugs into the cochlear perilymph through a single inlet hole in scala tympani of the basal turn was developed. The performance of a prototype, extracorporeal reciprocating perfusion system in guinea pigs is described. Analysis of the cochlear distribution of compounds after perfusion took advantage of the place-dependent generation of responses to tones along the length of the cochlea. Perfusion with a control artificial perilymph solution had no effect. Two drugs with wellcharacterized effects on cochlear physiology, salicylate (5 mM) and DNQX (6,7-Dinitroquinoxaline-2,3-dione; 100 and 300 μM), reversibly altered responses. The magnitude of drug effect decreased with distance from the perfusion pipette for up to 10 mm, and increased with dose and length of application.
“…OAEs, described by Kemp in 1978 14 , arise apparently in the OHC 2,15,16 and possibly represent the rapid contractions of this cell group. They are acoustic phenomena of cochlear nature, which reverberate through the ossicles in the middle ear and are transmitted to the ear canal, where they can be captured through a microphone.…”
“…The prevalence of hearing disorders as per various studies is [1] WHO 1967, 0.1 %; [2] BIRREL.J.F. 1986, 0.12 %; [3] FRASER.G.R.…”
Section: Discussionmentioning
confidence: 99%
“…The electro motility of the OHCs has a feedback effect on the basilar membrane, causing it to vibrate. Therefore, the electromotility of the OHCs is thought to be the mechanism which underlies OAEs [2,7]. Using OAEs to monitor ototoxic medications is logical.…”
The primary purpose of this study was to investigate the potential role of transient-evoked Otoacoustic emissions (TEOAEs) beyond screening for hearing impairment in different middle/inner ear disorders in 3-65 years age group. Because TEOAEs are present in ears with normal cochlear and middle ear function and typically are absent or reduced in ears with cochlear and/or middle ear disorders of even mild degree. This was a prospective study of four hundred cases. Out of these 364 cases were having problems related to otology and 36 were healthy volunteers who attended the department of otorhinolaryngology of our institute. All the cases were kept in different eight groups and then subjected to Otoacoustic emission testing with the 'GSI AUDIO screener' equipment installed in our ENT department. The data obtained in all groups were analyzed and conclusion was made. TEOAEs is a reliable, simple and cost effective screening technique for hearing disorders with sensitivity varying from 72 to 96.42 % among the study groups and 88 % in composite group comprising all study groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.